These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

517 related articles for article (PubMed ID: 33522942)

  • 1. A false alarm of COVID-19 pneumonia in lung cancer with anti-PD-1 related pneumonitis: a case report and review of the literature.
    Dai Y; Liu S; Zhang Y; Li X; Zhao Z; Liu P; Du Y
    J Med Case Rep; 2021 Feb; 15(1):41. PubMed ID: 33522942
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pneumonitis from immune checkpoint inhibitors and COVID-19: current concern in cancer treatment.
    Rossi E; Schinzari G; Tortora G
    J Immunother Cancer; 2020 Jul; 8(2):. PubMed ID: 32699182
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Rifampicin-Induced Pneumonitis Mimicking Severe COVID-19 Pneumonia Infection.
    Ata F; Shaher Mousa Hussein M; Mismar AY; Sharma R; Bozom IAM; Alsiddig Ali Ibrahim Z; Ibrahim WH
    Am J Case Rep; 2020 Aug; 21():e927586. PubMed ID: 32840240
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Immune-related pneumonitis caused by programmed death-1 inhibitor Pembrolizumab: a case report and literature review].
    Chen YL; Zhao J; Jia R; Wang HY; Zheng J; Bai CQ; Wang MZ; Xu JM
    Zhonghua Jie He He Hu Xi Za Zhi; 2017 Oct; 40(10):736-743. PubMed ID: 29050127
    [No Abstract]   [Full Text] [Related]  

  • 5. Imaging and clinical features of patients with 2019 novel coronavirus SARS-CoV-2.
    Xu X; Yu C; Qu J; Zhang L; Jiang S; Huang D; Chen B; Zhang Z; Guan W; Ling Z; Jiang R; Hu T; Ding Y; Lin L; Gan Q; Luo L; Tang X; Liu J
    Eur J Nucl Med Mol Imaging; 2020 May; 47(5):1275-1280. PubMed ID: 32107577
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and radiological features of immune checkpoint inhibitor-related pneumonitis in lung cancer and non-lung cancers.
    Nobashi TW; Nishimoto Y; Kawata Y; Yutani H; Nakamura M; Tsuji Y; Yoshida A; Sugimoto A; Yamamoto T; Alam IS; Noma S
    Br J Radiol; 2020 Nov; 93(1115):20200409. PubMed ID: 32783627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Thoracic Imaging of Non-Small Cell Lung Cancer Treated With Anti-programmed Death Receptor-1 Therapy.
    Hammer M; Bagley S; Aggarwal C; Bauml J; Nachiappan AC; Simone CB; Langer C; Katz SI
    Curr Probl Diagn Radiol; 2019; 48(2):142-147. PubMed ID: 29573843
    [TBL] [Abstract][Full Text] [Related]  

  • 8. COVID-19 lung injury as a primer for immune checkpoint inhibitors (ICIs)-related pneumonia in a patient affected by squamous head and neck carcinoma treated with PD-L1 blockade: a case report.
    Dipasquale A; Persico P; Lorenzi E; Rahal D; Santoro A; Simonelli M
    J Immunother Cancer; 2021 Feb; 9(2):. PubMed ID: 33574054
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pneumonitis: a serious adverse effect of PD-L1 inhibitors including pembrolizumab.
    Rickard F; Hyams C; Low AT
    BMJ Case Rep; 2018 May; 2018():. PubMed ID: 29735504
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Atypical Chest Computed Tomography Finding of Predominant Interstitial Thickening in a Patient with Coronavirus Disease 2019 (COVID-19) Pneumonia.
    Lau JYC; Khoo HW; Hui TCH; Kaw GJL; Tan CH
    Am J Case Rep; 2020 Sep; 21():e926781. PubMed ID: 32952147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prognostic significance of the radiologic features of pneumonitis induced by anti-PD-1 therapy.
    Watanabe S; Ota T; Hayashi M; Ishikawa H; Otsubo A; Shoji S; Nozaki K; Ichikawa K; Kondo R; Miyabayashi T; Miura S; Tanaka H; Abe T; Okajima M; Terada M; Ishida T; Iwashima A; Sato K; Yoshizawa H; Kikuchi T
    Cancer Med; 2020 May; 9(9):3070-3077. PubMed ID: 32150668
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Radiologic and autopsy findings in a case of fatal immune checkpoint inhibitor-associated pneumonitis.
    Shea M; Rangachari D; Hallowell RW; Hollie NI; Costa DB; VanderLaan PA
    Cancer Treat Res Commun; 2018; 15():17-20. PubMed ID: 30207283
    [TBL] [Abstract][Full Text] [Related]  

  • 13. COVID-19 in a patient with advanced Merkel cell carcinoma receiving immunotherapy.
    da Costa CM; de Souza ZS; Real Salgues AC; Harada G; Marino Rodrigues Ayres PP; Vieira Nunes DB; Katz A; Munhoz RR
    Immunotherapy; 2020 Oct; 12(15):1133-1138. PubMed ID: 32900245
    [No Abstract]   [Full Text] [Related]  

  • 14. Incidence of Pneumonitis With Use of Programmed Death 1 and Programmed Death-Ligand 1 Inhibitors in Non-Small Cell Lung Cancer: A Systematic Review and Meta-Analysis of Trials.
    Khunger M; Rakshit S; Pasupuleti V; Hernandez AV; Mazzone P; Stevenson J; Pennell NA; Velcheti V
    Chest; 2017 Aug; 152(2):271-281. PubMed ID: 28499515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A COVID-19 patient with multiple negative results for PCR assays outside Wuhan, China: a case report.
    Chen LD; Li H; Ye YM; Wu Z; Huang YP; Zhang WL; Lin L
    BMC Infect Dis; 2020 Jul; 20(1):517. PubMed ID: 32677909
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Can Chest CT Features Distinguish Patients With Negative From Those With Positive Initial RT-PCR Results for Coronavirus Disease (COVID-19)?
    Chen D; Jiang X; Hong Y; Wen Z; Wei S; Peng G; Wei X
    AJR Am J Roentgenol; 2021 Jan; 216(1):66-70. PubMed ID: 32368928
    [No Abstract]   [Full Text] [Related]  

  • 17. Correlation between Chest Computed Tomography and Lung Ultrasonography in Patients with Coronavirus Disease 2019 (COVID-19).
    Tung-Chen Y; Martí de Gracia M; Díez-Tascón A; Alonso-González R; Agudo-Fernández S; Parra-Gordo ML; Ossaba-Vélez S; Rodríguez-Fuertes P; Llamas-Fuentes R
    Ultrasound Med Biol; 2020 Nov; 46(11):2918-2926. PubMed ID: 32771222
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Nasopharyngeal Carcinoma Patient With COVID-19 Infection After Immunotherapy: A Case Report and Literature Review.
    Zhai M; Zhang S
    In Vivo; 2020; 34(6):3753-3756. PubMed ID: 33144494
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Anti-PD-1 Inhibitor-Related Pneumonitis in Non-Small Cell Lung Cancer.
    Nishino M; Chambers ES; Chong CR; Ramaiya NH; Gray SW; Marcoux JP; Hatabu H; Jänne PA; Hodi FS; Awad MM
    Cancer Immunol Res; 2016 Apr; 4(4):289-93. PubMed ID: 26865455
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pre-existing pulmonary fibrosis is a risk factor for anti-PD-1-related pneumonitis in patients with non-small cell lung cancer: A retrospective analysis.
    Yamaguchi T; Shimizu J; Hasegawa T; Horio Y; Inaba Y; Yatabe Y; Hida T
    Lung Cancer; 2018 Nov; 125():212-217. PubMed ID: 30429022
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 26.